about
Tracking Strains in the Microbiome: Insights from Metagenomics and ModelsBreaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disordersThe role of the commensal microbiota in the regulation of tolerance to dietary allergensBeneficial Microbes: The pharmacy in the gutMicrobiota and pathogen 'pas de deux': setting up and breaking down barriers to intestinal infection.Personalized nutrition through big data.The microbiome in inflammatory bowel disease: current status and the future ahead.A proposed definition of microbiota transplantation for regulatory purposes.Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology.Determining microbial products and identifying molecular targets in the human microbiome.Science and regulation. Probiotics: finding the right regulatory balance.Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease.The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.A clinician's guide to microbiome analysis.Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects.The human microbiome and metabolomics: Current concepts and applications.Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.The Influence of the Microbiome on Allergic Sensitization to Food.Transmission of the gut microbiota: spreading of health.The contribution of microbial biotechnology to sustainable development goals: microbiome therapies.All signals lost.To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes.Elucidation of complexity and prediction of interactions in microbial communities.Beneficial Microbes: The pharmacy in the gut.Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.Association Between Gut Microbiota and Bone Health: Potential Mechanisms and Prospective.Microbial Regulation of Glucose Metabolism and Insulin Resistance.Fecal transplantation poses dilemma for FDA.Computer-guided design of optimal microbial consortia for immune system modulation.First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.Role of the gut microbiota in nutrition and health.The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating InflammationExperimental evaluation of the importance of colonization history in early-life gut microbiota assembly
P2860
Q26744668-A77E76E9-9DD9-4836-BF58-3FB8D09818B2Q26777279-906429B1-788B-4066-9D23-6C2240F45008Q26829166-344D2E6D-0D01-4D44-99C1-33966C91FBEFQ28067936-41FDE605-E924-429E-B2EC-EE5E15293130Q30276689-9C8F8AF5-B745-4E26-9655-5F5AD5A60333Q31043257-98E41FFF-5E83-495E-94FC-7C2B584538D1Q33664898-BDC46200-F5B0-4235-882C-7F171773BA8EQ33821339-AFC19C80-6550-45D7-A0C6-BFCBE685A397Q34615534-34BD6EB0-1D4A-459F-991C-A00E7698719CQ34625923-F103CD38-401D-45FF-B981-EDBEE76E6E7FQ35020179-A06A868E-6E43-4968-BEB7-C486944E1687Q35094314-EE375BFD-5F50-443A-B014-A84BCB8F8875Q35762027-8436ED93-DBBA-4522-9BA3-77D6A113CE40Q35994584-912447C2-A03F-428C-9ECB-3FD3CE1FD80EQ36038992-4C22477C-3BB3-44B2-BD60-7D20F8D5B3D1Q38645218-3896FA44-A405-438A-97F2-37F536F8EB0BQ38806283-FF225679-29E8-4B40-9628-728D0294F557Q38808222-181F839D-4C91-4054-9B0D-B20BC2F1E2A2Q39077398-D7CCD3EF-CF10-49F0-BD04-D039D80B133FQ39077406-0B70F451-49A1-405A-AD40-12B92A441F76Q39365653-63028A49-1FFF-4873-BCE9-066B5E966472Q41693402-291710BE-EB87-428A-AFD8-2982310DB7B7Q42406980-0BB87F43-698E-4373-A3AE-B44D179EF12CQ44401760-249C12D1-03B2-4F6A-8F63-DFE3067833C9Q45017953-39DCF586-7429-4B97-B1E0-D0B13C850F04Q46055149-BE97BA53-39FF-4525-9618-5B64DA0BE80BQ46284784-312907FE-1060-4273-882A-FF48F415131EQ46296054-797956F6-BA6B-46A1-AD2B-A857A8A8DEE7Q47235131-A8349ADF-EBD4-4A51-B241-B59C007816EBQ47878259-244A8D8A-6DFA-47F6-B861-9946A3D33A17Q52583327-5F29CC85-B013-44F8-8A84-C4F9928AFE5AQ53826618-1EF39882-DDE2-487C-AB60-F532A073FE87Q55383691-D65219F7-C76C-4631-A9A7-A818B3B7D4BFQ57174271-2B4C472F-205F-4EC5-83BD-4083630B3649Q58726997-367E0392-CE45-4838-B154-BACA26FA79C4
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Medicines from microbiota.
@en
Medicines from microbiota.
@nl
type
label
Medicines from microbiota.
@en
Medicines from microbiota.
@nl
prefLabel
Medicines from microbiota.
@en
Medicines from microbiota.
@nl
P2860
P356
P1433
P1476
Medicines from microbiota.
@en
P2093
Bernat Olle
P2860
P2888
P304
P356
10.1038/NBT.2548
P577
2013-04-01T00:00:00Z